Promotion of colorectal cancer progression by immune-related lnc-SOX9–4 via suppression of YBX1 poly-ubiquitination and degradation

Yan Zhao,Sheng Yang,Hongxu Nie,Dongsheng Zhang,Tuo Wang,Qingyang Sun,Xiaowei Wang,Yueming Sun
DOI: https://doi.org/10.1016/j.cellsig.2023.110854
IF: 4.85
2023-08-23
Cellular Signalling
Abstract:Background Recent research has highlighted the versatile functions of long non-coding RNAs (lncRNAs) in the onset and progression of various malignancies. Still, insufficient knowledge is available on how lnc-SOX9–4 functions in colorectal cancer (CRC) progression. Methods Bioinformatics analysis was used to identify a novel lncRNA (lnc-SOX9–4), and the expression pattern of the RNA in CRC was verified using qRT-PCR. Gene ontology (GO) term analysis and Gene set enrichment analysis (GSEA) were implemented for the identification of the related mechanisms and roles of lnc-SOX9–4. Immune infiltration analysis was conducted for assessment of how lnc-SOX9–4 is linked to tumor immune cell infiltration level. Both in vitro and in vivo phenotype analyses were conducted for scrutinizing how lnc-SOX9–4 impacts the proliferation and metastasis of CRC. RNA pulldown, mass spectrometry analysis, fluorescent in situ hybridization (FISH), western blotting, and RIP assay aided in verifying lnc-SOX9–4 mechanisms linked to CRC progression. Results An upregulation of lnc-SOX9–4 was observed in the sample CRC cells and tissues. Elevated lnc-SOX9–4 levels showed a positive association with poor clinical prognosis. Lnc-SOX9–4 was closely correlated to several types of immune infiltrating cells. Functionally, the knockdown of lnc-SOX9–4 significantly inhibited CRC cell proliferation, migration, and invasion abilities. Mechanistically, YBX1 was identified as lnc-SOX9–4, specifically interacting protein in the nucleus. Lnc-SOX9–4 could stabilize YBX1 protein levels by inhibiting poly-ubiquitination and degradation of YBX1. Furthermore, phenotype rescue experiments reveal that lnc-SOX9–4 enhanced the CRC cellular potential to proliferate and metastasize by regulating YBX1 levels. Conclusions Lnc-SOX9–4 promoted CRC progression by suppressing cytoplasmic translocation and promoting protein levels of YBX1 can serve as novel treatment targets for diagnosing and treating CRC.
cell biology
What problem does this paper attempt to address?